Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ASP Isotopes, the most common co-covered peer. Source depth averages 2 original sources per story, versus 4.7 across the same-window beat baseline.
Last mentioned: Feb 26, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ASP Isotopes, the most common co-covered peer. Source depth averages 2 original sources per story, versus 4.7 across the same-window beat baseline. The 6 average consequence score is above the beat benchmark of 5.6 in the same window. We currently track 1 Healthcare story that mention Paul Mann, all published on February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Paul Mann. Shared-story counts are live from our verified record — not editorial picks.
Commercial Ramp-Up
Targeted date for full-scale commercial isotope production and revenue growth.
QLE Spin-Off Planning
Strategic restructuring to separate enrichment tech from product verticals.
Emerging Growth Conference
CEO Paul Mann provides update on isotope production and 2026 strategy.
Silicon-28 Shipments
First shipments of high-purity Silicon-28 sent to semiconductor customers.
ASP Isotopes CEO Paul Mann outlined a strategic transition to a 2026 commercial ramp-up, highlighting progress in Silicon-28 shipments and a planned spin-off of its Quantum Laser Enrichment division. The company aims to address critical global shortages in medical isotopes and advanced materials for the semiconductor and nuclear sectors.
Source: The Lincolnian Online · Bbns
Paul Mann is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
